The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade.

@article{Roe1998TheET,
  title={The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade.},
  author={Matthew T. Roe and David J Moliterno},
  journal={Cleveland Clinic journal of medicine},
  year={1998},
  volume={65 5},
  pages={267-72}
}